Neurocrine Biosciences, Inc.
(NASDAQ : NBIX)

( )
NBIX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-1.94%88.651.3%$796.69m
AMGNAmgen Inc.
-0.76%185.501.2%$630.51m
GILDGilead Sciences, Inc.
-2.14%65.550.9%$497.34m
BIIBBiogen Inc.
-4.17%321.171.3%$426.56m
ILMNIllumina, Inc.
-1.77%296.883.5%$314.34m
REGNRegeneron Pharmaceuticals, Inc.
-0.92%418.622.6%$301.49m
VRTXVertex Pharmaceuticals Incorporated
-2.55%183.061.9%$262.15m
ALXNAlexion Pharmaceuticals, Inc.
-1.76%127.552.0%$232.43m
SRPTSarepta Therapeutics, Inc.
-2.87%136.5415.4%$150.79m
AAgilent Technologies, Inc.
-0.83%77.911.6%$143.97m
EXASExact Sciences Corporation
-0.42%83.2825.3%$128.91m
INCYIncyte Corporation
-0.49%83.332.5%$114.75m
ARRYArray BioPharma Inc.
-1.99%22.718.2%$107.63m
EXELExelixis, Inc.
-0.09%21.226.4%$83.96m
NBIXNeurocrine Biosciences, Inc.
-2.58%77.315.1%$78.49m

Company Profile

Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.